Oscar Health (OSCR) Earnings Analysis

Oscar Health (OSCR) next reports earnings on 2026-08-06, consensus EPS 0.34 USD. Last quarter (2025-11-06) it beat with EPS -0.53 USD vs -0.55 USD est (+3.6%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -77.63.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does OSCR next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate0.34 USD
Revenue estimate4.72B

OSCR earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-11-06-0.53 USD-0.55 USD+3.6%Beat
2024-11-07-0.22 USD-0.2 USD-10%Miss

Beat rate: 1/2 (50%) over reported quarters with consensus data.

OSCR valuation and analyst view

Trailing P/E-77.63
Trailing EPS-0.13222 USD
Price / book5.29
Dividend yield0.00%
Market cap7.74B
Analyst consensusHold (3 buy / 6 hold / 2 sell)
Avg price target26 USD

Related research pages

Frequently asked questions

When is Oscar Health (OSCR)'s next earnings date?

Oscar Health is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.34 USD and revenue estimate of 4.72B.

Did OSCR beat earnings last quarter?

In its 2025-11-06 report, OSCR posted EPS of -0.53 USD versus a -0.55 USD estimate — a beat of 3.6%.

What is OSCR's earnings track record?

Over the last 2 reported quarters with consensus data, OSCR beat estimates 1 times (50%).

What is OSCR's current P/E ratio and EPS?

OSCR trades at a trailing P/E of -77.63 on trailing EPS of -0.13222037399726344 USD.

What do analysts rate OSCR?

Analyst consensus is "Hold" across 11 ratings (0 strong buy, 3 buy, 6 hold, 2 sell, 0 strong sell). Average 12-month price target: 26 USD.